Research map: Cell-specific ERK2 signaling in vascular smooth muscle cells drives vascular dysfunction and systolic heart failure

Back to the article

Papers in this map

  1. Salmon provides fast and bias-aware quantification of transcript expression · Rob Patro · 2017 · 14229 citations · Cited by this paper
  2. From antioxidant hype to mitochondrial reality: Quercetin modulates cardiac redox balance but fails to restore mitochondrial respiration parameters in Zucker diabetic fatty rats · 2026 · Related
  3. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia · Stephen G. O’Brien · 2003 · 3596 citations · Cited by this paper
  4. Ligand-resolved in vivo phosphoproteomics of the adult heart maps ErbB signaling by EGF and NRG1β · 2026 · Related
  5. AdapterRemoval v2: rapid adapter trimming, identification, and read merging · Mikkel Schubert · 2016 · 2336 citations · Cited by this paper
  6. Loss of phospholamban phosphorylation blunts Ca2+ handling during the cellular adrenergic response · 2026 · Related
  7. Targeting RAS–ERK signalling in cancer: promises and challenges · Ahmed A. Samatar · 2014 · 1230 citations · Cited by this paper
  8. Transcription initiation factor-1A regulates the contraction of vascular smooth muscle and maintains blood pressure · 2026 · Related
  9. Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice · Gilles Pagès · 1999 · 653 citations · Cited by this paper
  10. CYLD-mediated DNA damage coordinates pathological cardiac hypertrophy via RIPK1-dependent signaling · 2026 · Related
  11. RhoA/Rho-Kinase in the Cardiovascular System · Hiroaki Shimokawa · 2016 · 491 citations · Cited by this paper
  12. A review of peroxisome biology: Potential implications for cardiac physiology and pathology · 2026 · Related
  13. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice · Gianluigi Condorelli · 2002 · 462 citations · Cited by this paper
  14. Cardiomyopathy and aging integrally contribute to the unfolded protein response collective pathways · 2026 · Related
  15. Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics · Ming Hui Chen · 2008 · 380 citations · Cited by this paper
  16. Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome · 2026 · Related
  17. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. · L Li · 1996 · 325 citations · Cited by this paper
  18. Melatonin promotes coronary angiogenesis and ameliorates cardiac dysfunction after myocardial infarction via endothelial LRRC8A · 2026 · Related
  19. Somatic Mutations ofEGFRin Colorectal Cancers and Glioblastomas · Thomas D. Barber · 2004 · 316 citations · Cited by this paper
  20. Sex differences in mitochondrial Ca2+ during ischemia/reperfusion injury: A role for S-Nitrosylation · 2026 · Related
  21. Essential role for ERK2 mitogen‐activated protein kinase in placental development · Naoya Hatano · 2003 · 299 citations · Cited by this paper
  22. ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy? · Roser Buscà · 2016 · 295 citations · Cited by this paper
  23. Physiological Diagnostic Criteria for Vascular Failure · Atsushi Tanaka · 2018 · 290 citations · Cited by this paper
  24. Restricted inactivation of serum response factor to the cardiovascular system · Joseph M. Miano · 2004 · 268 citations · Cited by this paper
  25. Extracellular Signal-Regulated Kinases 1 and 2 Regulate the Balance Between Eccentric and Concentric Cardiac Growth · Izhak Kehat · 2010 · 266 citations · Cited by this paper
  26. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt · T MATSUI · 2004 · 262 citations · Cited by this paper
  27. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo · Nicole H. Purcell · 2007 · 248 citations · Cited by this paper
  28. Myocardial AKT: The Omnipresent Nexus · Mark Alan Sussman · 2011 · 229 citations · Cited by this paper
  29. Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors · Stergios J. Moschos · 2018 · 153 citations · Cited by this paper
  30. ERK2 Contributes to the Control of Social Behaviors in Mice · Yasushi Satoh · 2011 · 146 citations · Cited by this paper
  31. Coronary blood flow in heart failure: cause, consequence and bystander · Gerd Heusch · 2022 · 144 citations · Cited by this paper
  32. Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study · Preetesh Jain · 2015 · 108 citations · Cited by this paper
  33. Effects of insulin resistance on skeletal muscle growth and exercise capacity in type 2 diabetic mouse models · Joseph E. Ostler · 2014 · 106 citations · Cited by this paper
  34. Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies · Anand Prakash Singh · 2019 · 92 citations · Cited by this paper
  35. A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity · Hui Wen Cheng · 2011 · 89 citations · Cited by this paper
  36. A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors · Andréa Varga · 2019 · 89 citations · Cited by this paper
  37. Ponatinib reduces viability, migration, and functionality of human endothelial cells · Ayala Gover‐Proaktor · 2016 · 75 citations · Cited by this paper
  38. Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and Disease · Mazen Kurdi · 2018 · 74 citations · Cited by this paper
  39. Loss of Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells and Cardiomyocytes Causes Arterial Hypotension and Cardiac Hypertrophy · Barbara Schreier · 2012 · 72 citations · Cited by this paper

Source: OpenAlex (CC0)